Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Aprepitant Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Aprepitant Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Purity;98%-99%
      • 1.3.3 Purity:>99%
    • 1.4 Market Segment by Application
      • 1.4.1 Global Aprepitant Market Share by Application (2019-2025)
      • 1.4.2 Prevent Postoperative Nausea and Vomiting
      • 1.4.3 Preventing Cancer from Vomiting
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Aprepitant Production Value 2014-2025
      • 2.1.2 Global Aprepitant Production 2014-2025
      • 2.1.3 Global Aprepitant Capacity 2014-2025
      • 2.1.4 Global Aprepitant Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Aprepitant Market Size CAGR of Key Regions
      • 2.2.2 Global Aprepitant Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Aprepitant Capacity by Manufacturers
      • 3.1.2 Global Aprepitant Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Aprepitant Revenue by Manufacturers (2014-2019)
      • 3.2.2 Aprepitant Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Aprepitant Market Concentration Ratio (CR5 and HHI)
    • 3.3 Aprepitant Price by Manufacturers
    • 3.4 Key Manufacturers Aprepitant Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Aprepitant Market
    • 3.6 Key Manufacturers Aprepitant Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Purity;98%-99% Production and Production Value (2014-2019)
      • 4.1.2 Purity:>99% Production and Production Value (2014-2019)
    • 4.2 Global Aprepitant Production Market Share by Type
    • 4.3 Global Aprepitant Production Value Market Share by Type
    • 4.4 Aprepitant Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Aprepitant Consumption by Application

    6 Production by Regions

    • 6.1 Global Aprepitant Production (History Data) by Regions 2014-2019
    • 6.2 Global Aprepitant Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Aprepitant Production Growth Rate 2014-2019
      • 6.3.2 United States Aprepitant Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Aprepitant Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Aprepitant Production Growth Rate 2014-2019
      • 6.4.2 European Union Aprepitant Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Aprepitant Import & Export
    • 6.5 China
      • 6.5.1 China Aprepitant Production Growth Rate 2014-2019
      • 6.5.2 China Aprepitant Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Aprepitant Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Aprepitant Consumption by Regions

    • 7.1 Global Aprepitant Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Aprepitant Consumption by Type
      • 7.2.2 United States Aprepitant Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Aprepitant Consumption by Type
      • 7.3.2 European Union Aprepitant Consumption by Application
    • 7.4 China
      • 7.4.1 China Aprepitant Consumption by Type
      • 7.4.2 China Aprepitant Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Aprepitant Consumption by Type
      • 7.5.2 Rest of World Aprepitant Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Mehta
      • 8.1.1 Mehta Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Aprepitant
      • 8.1.4 Aprepitant Product Introduction
      • 8.1.5 Mehta Recent Development
    • 8.2 Admiron
      • 8.2.1 Admiron Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Aprepitant
      • 8.2.4 Aprepitant Product Introduction
      • 8.2.5 Admiron Recent Development
    • 8.3 Bondbay Pharma
      • 8.3.1 Bondbay Pharma Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Aprepitant
      • 8.3.4 Aprepitant Product Introduction
      • 8.3.5 Bondbay Pharma Recent Development
    • 8.4 Jubilant Pharma
      • 8.4.1 Jubilant Pharma Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Aprepitant
      • 8.4.4 Aprepitant Product Introduction
      • 8.4.5 Jubilant Pharma Recent Development
    • 8.5 Neuraxpharm
      • 8.5.1 Neuraxpharm Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Aprepitant
      • 8.5.4 Aprepitant Product Introduction
      • 8.5.5 Neuraxpharm Recent Development
    • 8.6 Hetero
      • 8.6.1 Hetero Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Aprepitant
      • 8.6.4 Aprepitant Product Introduction
      • 8.6.5 Hetero Recent Development
    • 8.7 Farmhispania
      • 8.7.1 Farmhispania Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Aprepitant
      • 8.7.4 Aprepitant Product Introduction
      • 8.7.5 Farmhispania Recent Development
    • 8.8 Cayman
      • 8.8.1 Cayman Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Aprepitant
      • 8.8.4 Aprepitant Product Introduction
      • 8.8.5 Cayman Recent Development
    • 8.9 Piramal Pharma Solutions
      • 8.9.1 Piramal Pharma Solutions Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Aprepitant
      • 8.9.4 Aprepitant Product Introduction
      • 8.9.5 Piramal Pharma Solutions Recent Development
    • 8.10 Beijing Langfang Gaobo Jingbang Pharmaceutical
      • 8.10.1 Beijing Langfang Gaobo Jingbang Pharmaceutical Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Aprepitant
      • 8.10.4 Aprepitant Product Introduction
      • 8.10.5 Beijing Langfang Gaobo Jingbang Pharmaceutical Recent Development
    • 8.11 Zhongshan Enantiotech Corporation
    • 8.12 Nanjing Gold Pharmaceutical Technology
    • 8.13 Zhongshan Follow Biotech
    • 8.14 Rxn chemicals
    • 8.15 RA Chem Pharma Limited
    • 8.16 Tofigh Daru
    • 8.17 Royesh Daru Pars Co
    • 8.18 Wujiang Xiehe Pharmaceutical
    • 8.19 Wuhai Yuancheng Technology
    • 8.20 Chengdu Henghui Pharmaceutical

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Aprepitant Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Aprepitant Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Aprepitant Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Aprepitant Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Aprepitant Production Forecast by Type
      • 9.7.2 Global Aprepitant Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Aprepitant Sales Channels
      • 10.2.2 Aprepitant Distributors
    • 10.3 Aprepitant Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Aprepitant is an antiemetic compound and belongs to a class of drugs called substance P antagonists (SPA). It mediates its effects by blocking the neurokinin 1 (NK 1) receptor.
      In 2019, the market size of Aprepitant is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Aprepitant.

      This report studies the global market size of Aprepitant, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Aprepitant production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Mehta
      Admiron
      Bondbay Pharma
      Jubilant Pharma
      Neuraxpharm
      Hetero
      Farmhispania
      Cayman
      Piramal Pharma Solutions
      Beijing Langfang Gaobo Jingbang Pharmaceutical
      Zhongshan Enantiotech Corporation
      Nanjing Gold Pharmaceutical Technology
      Zhongshan Follow Biotech
      Rxn chemicals
      RA Chem Pharma Limited
      Tofigh Daru
      Royesh Daru Pars Co
      Wujiang Xiehe Pharmaceutical
      Wuhai Yuancheng Technology
      Chengdu Henghui Pharmaceutical

      Market Segment by Product Type
      Purity;98%-99%
      Purity:>99%

      Market Segment by Application
      Prevent Postoperative Nausea and Vomiting
      Preventing Cancer from Vomiting

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Aprepitant status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Aprepitant manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Aprepitant are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now